Davis Polk
David R. Bauer
- Deals
- 9
- Latest
- Jul 2026
- Most deals in
- Specialty Materials
Firm
- Davis Polk Law firm · 2026 · 9 deals
Often works with
- Veronica M. Wissel 4 deals together
- William A. Curran 4 deals together
- Adam Kaminsky 3 deals together
- Harold Birnbaum 3 deals together
- Samantha Lefland 3 deals together
- Evan Rosen 2 deals together
- Rahul Srivastava 2 deals together
- Robert F. Smith 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jul 2026 | IPS Adhesives | Parent company of IPS | Matrix Adhesives Group | Asset sale | Legal adviser to TruArc Partners, LP and its portfolio company, Matrix Adhesives Group (acquirer) | Completed | – | Specialty Materials+2 | Matrix Adhesives Group acquisition of IPS Adhesives |
| Jun 2026 | TARGAN | – | Merck Animal Health | Acquisition | Legal adviser to TARGAN (target) | Announced | – | Agtech+2 | Merck Animal Health acquisition of TARGAN |
| Jun 2026 | SAGA Diagnostics | – | Roche | Acquisition | Legal adviser to Roche (acquirer) | Announced | 595.0 | Diagnostics+1 | Roche acquisition of SAGA Diagnostics |
| May 2026 | PathAI | – | Roche | Acquisition | Legal adviser to Roche (acquirer) | Pending | 750.0 | Healthcare Software+2 | Roche acquisition of PathAI |
| Mar 2026 | Matrix Adhesives Group | Goldner Hawn | TruArc Partners, LP | Acquisition | Legal adviser to TruArc Partners, LP (acquirer) | Completed | – | Specialty Materials+2 | TruArc Partners, LP acquisition of Matrix Adhesives Group |
| Mar 2026 | Data Dimensions | Thompson Street Capital Partners | One Call | Acquisition | Legal adviser to One Call (acquirer) | Announced | – | Business Services+2 | One Call acquisition of Data Dimensions |
| Feb 2026 | Uromedica | – | Coloplast A/S | Acquisition | Legal adviser to Coloplast A/S (acquirer) | Announced | – | Medtech | Coloplast A/S acquisition of Uromedica |
| Jan 2026 | AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 | AbelZeta | AstraZeneca | Asset sale | Legal adviser to AbelZeta (target) | Announced | 630.0 | Biotech+2 | AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 |
| Jan 2026 | Conformal Medical | – | W. L. Gore & Associates | Acquisition | Legal adviser to W. L. Gore & Associates (acquirer) | Announced | – | Medtech+1 | W. L. Gore & Associates acquisition of Conformal Medical |
Deals where David R. Bauer is named on the firm's deal team, by the firm or the press.